1.Carbonetti, NH (2016) Bordetella pertussis: new concepts in pathogenesis and treatment. Current Opinion in Infectious Diseases 29, 287–294.
2.Sato, Y, Kimura, M and Fukumi, H (1984) Development of a pertussis component vaccine in Japan. Lancet 1, 122–126.
3.Perez-Perez, GF et al. (2015) Pertussis in Mexico, an epidemiological overview. A study of 19 years at the Institute Mexicano del Seguro Social. Revista medica del Instituto Mexicano del Seguro Social 52, 164–170.
8.Mooi, FR, Van Der Maas, NA and De Melker, HE (2014) Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiology and Infection 142, 685–694.
9.Warfel, JM, Zimmerman, LI and Merkel, TJ (2014) Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proceedings of the National Academy of Sciences of the United States of America 111, 787–792.
10.Mooi, FR et al. (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerging Infectious Diseases 15, 1206–1213.
11.Bailon, H et al. (2016) Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Peru, 2012. BMC Infectious Diseases 16, 422.
12.Clarke, M et al. (2016) The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. The Journal of Infection 72, 171–178.
13.Bouchez, V et al. (2015) New data on vaccine antigen deficient Bordetella pertussis isolates. Vaccines 3, 751–770.
14.Campbell, P et al. (2012) Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS ONE 7, e35874.
15.Witt, MA, Katz, PH and Witt, DJ (2012) Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 54, 1730–1735.
16.Miyaji, Y et al. (2013) Genetic analysis of Bordetella pertussis isolates from the 2008–2010 pertussis epidemic in Japan. PLoS ONE 8, e77165.
17.Fathima, S et al. (2014) Bordetella pertussis in sporadic and outbreak settings in Alberta, Canada, July 2004-December 2012. BMC Infectious Diseases 14, 48.
18.Rocha, EL et al. (2017) The characterization of Bordetella pertussis strains isolated in the Central-Western region of Brazil suggests the selection of a specific genetic profile during 2012–2014 outbreaks. Epidemiology and Infection 145, 1392–1397.
21.Tatti, KM et al. (2011) Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. Journal of Clinical Microbiology 49, 4059–4066.
22.Bisgard, KM et al. (2001) Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989–1996. The Journal of Infectious Diseases 183, 1360–1367.
23.Tenover, FC et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233–2239.
24.Schmidtke, AJ et al. (2012) Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerging Infectious Diseases 18, 1248–1255.
25.Borisova, O et al. (2007) Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clinical and Vaccine Immunology: CVI 14, 234–238.
26.King, AJ et al. (2013) Genome-wide gene expression analysis of Bordetella pertussis isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains. PLoS ONE 8, e66150.
27.Kurniawan, J et al. (2010) Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis. Emerging Infectious Diseases 16, 297–300.
28.Lam, C et al. (2014) Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerging Infectious Diseases 20, 626–633.
29.Pawloski, LC et al. (2014) Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clinical and Vaccine Immunology: CVI 21, 119–125.
30.Safarchi, A et al. (2016) Genomic dissection of Australian Bordetella pertussis isolates from the 2008–2012 epidemic. The Journal of Infection 72, 468–477.
31.Conde-Glez, C et al. (2014) Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study. Epidemiology and Infection 142, 706–713.
32.Bisgard, KM et al. (2004) Infant pertussis: who was the source? The Pediatric Infectious Disease Journal 23, 985–989.
33.de Greeff, SC et al. (2010) Pertussis disease burden in the household: how to protect young infants. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 50, 1339–1345.
34.Wendelboe, AM et al. (2007) Transmission of Bordetella pertussis to young infants. The Pediatric Infectious Disease Journal 26, 293–299.
35.Tatti, KM et al. (2008) Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagnostic Microbiology and Infectious Disease 61, 264–272.